Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Persistent Airway Inflammation and Bronchial Hyperresponsiveness in Patients With Totally Controlled
Link ID 9797
Title Persistent Airway Inflammation and Bronchial Hyperresponsiveness in Patients With Totally Controlled
Url http://www.medscape.com/viewarticle/581411?src=rss
Description Can airway inflammation and bronchial hyperresponsiveness still persist during total control of asthma?
International Journal of Clinical Practice
Category Articles > Allergy and Clinical Immunology
Keywords
Date Oct 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. P4P Update: Doctors Have Slowed its Spread, but is That a Mistake?
  Many doctors have rejected pay-for-performance programs, but they may be missing out on some useful benefits. Medscape Business of Medicine
Category:   Articles > Allergy and Clinical Immunology


2. Pelosi: No U.S. Healthcare Bill Not a Possibility
  U.S. House Speaker Nancy Pelosi said on Wednesday she thought Democrats in Congress would still produce healthcare legislation despite recent difficulties, saying no bill was not an option. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


3. NCCN 2009: Recommendations on Managing Skin Toxicities With EGFR Inhibitors
  Dermatologic toxicities related to cancer treatment with epidermal growth-factor-receptor inhibitors should be treated reactively. Changes in therapy should be avoided if possible because rash is associated with improved outcome. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


4. FDA Approvals: Patanase, Actonel, Cimzia
  The FDA has approved olopatadineHCl nasal spray (Patanase), a once-monthly formulation for risedronate sodium tablets (Actonel), and certolizumab pegol powder for solution (Cimzia). Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


5. Half of Asthma Patients Do Not Respond to Standard TherapyHalf of Asthma Patients Do Not Respond to
  Current research and treatments target eosinophilic airway disease and neglect the many patients who are noneosinophilic. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS